Observe Medical at ICS 2026 in Maastricht

From 6 to 9 October we are at ICS 2026 in Maastricht, where our study on UnoMeter™ Safeti™ Max is on the scientific programme. In the 14-day in-vitro study from Karolinska Institutet, the silicone-oil barrier prevented retrograde migration of Proteus mirabilis. This is laboratory evidence of the mechanism, not a clinical outcome. CEO Jørgen Mann and the study authors look forward to meeting you.